309 related articles for article (PubMed ID: 34590194)
1. Glioma-Targeted Therapeutics: Computer-Aided Drug Design Prospective.
Poonan P; Agoni C; Ibrahim MAA; Soliman MES
Protein J; 2021 Oct; 40(5):601-655. PubMed ID: 34590194
[TBL] [Abstract][Full Text] [Related]
2. Emerging drugs for malignant glioma.
Mason WP
Expert Opin Emerg Drugs; 2008 Mar; 13(1):81-94. PubMed ID: 18321150
[TBL] [Abstract][Full Text] [Related]
3. Cell surface receptors in malignant glioma.
Li YM; Hall WA
Neurosurgery; 2011 Oct; 69(4):980-94; discussion 994. PubMed ID: 21522029
[TBL] [Abstract][Full Text] [Related]
4. Potential new targets and drugs related to histone modifications in glioma treatment.
Wei X; Xiao B; Wang L; Zang L; Che F
Bioorg Chem; 2021 Jul; 112():104942. PubMed ID: 33965781
[TBL] [Abstract][Full Text] [Related]
5. Targeting core (mutated) pathways of high-grade gliomas: challenges of intrinsic resistance and drug efflux.
Lin F; de Gooijer MC; Hanekamp D; Brandsma D; Beijnen JH; van Tellingen O
CNS Oncol; 2013 May; 2(3):271-88. PubMed ID: 25054467
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, DNA binding studies and evaluation of anticancer potential of novel substituted biscarbazole derivatives against human glioma U87 MG cell line.
Kumar N; Lal N; Nemaysh V; Luthra PM
Bioorg Chem; 2020 Jul; 100():103911. PubMed ID: 32502918
[TBL] [Abstract][Full Text] [Related]
8. Blood-Brain Barrier- and Blood-Brain Tumor Barrier-Penetrating Peptide-Derived Targeted Therapeutics for Glioma and Malignant Tumor Brain Metastases.
Chen L; Zeng D; Xu N; Li C; Zhang W; Zhu X; Gao Y; Chen PR; Lin J
ACS Appl Mater Interfaces; 2019 Nov; 11(45):41889-41897. PubMed ID: 31615203
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Molecular Diagnostics on the Treatment of Glioma.
Bush NA; Butowski N
Curr Oncol Rep; 2017 Apr; 19(4):26. PubMed ID: 28303493
[TBL] [Abstract][Full Text] [Related]
10. New treatment strategies for malignant gliomas.
Sathornsumetee S; Rich JN
Expert Rev Anticancer Ther; 2006 Jul; 6(7):1087-104. PubMed ID: 16831080
[TBL] [Abstract][Full Text] [Related]
11. Interferon-α/β enhances temozolomide activity against MGMT-positive glioma stem-like cells.
Shen D; Guo CC; Wang J; Qiu ZK; Sai K; Yang QY; Chen YS; Chen FR; Wang J; Panasci L; Chen ZP
Oncol Rep; 2015 Nov; 34(5):2715-21. PubMed ID: 26329778
[TBL] [Abstract][Full Text] [Related]
12. Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells.
Datta S; Sears T; Cortopassi G; Woolard K; Angelastro JM
Biomed Pharmacother; 2021 Jan; 133():111058. PubMed ID: 33378970
[TBL] [Abstract][Full Text] [Related]
13. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
[TBL] [Abstract][Full Text] [Related]
14. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
Chen R; Cohen AL; Colman H
Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978
[TBL] [Abstract][Full Text] [Related]
15. MR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound.
Timbie KF; Afzal U; Date A; Zhang C; Song J; Wilson Miller G; Suk JS; Hanes J; Price RJ
J Control Release; 2017 Oct; 263():120-131. PubMed ID: 28288892
[TBL] [Abstract][Full Text] [Related]
16. miR-149 rs2292832 C allele enhances the cytotoxic effect of temozolomide against glioma cells.
Xu B; Luo X; Ning X; Luo J; Guo J; Liu Q; Ling G
Neuroreport; 2020 Apr; 31(6):498-506. PubMed ID: 32243354
[TBL] [Abstract][Full Text] [Related]
17. Approaches toward improving the prognosis of pediatric patients with glioma: pursuing mutant drug targets with emerging small molecules.
Snape TJ; Warr T
Semin Pediatr Neurol; 2015 Mar; 22(1):28-34. PubMed ID: 25976258
[TBL] [Abstract][Full Text] [Related]
18. Novel approaches to glioma drug design and drug screening.
Patil SA; Hosni-Ahmed A; Jones TS; Patil R; Pfeffer LM; Miller DD
Expert Opin Drug Discov; 2013 Sep; 8(9):1135-51. PubMed ID: 23738794
[TBL] [Abstract][Full Text] [Related]
19. Low-grade gliomas.
Schiff D
Continuum (Minneap Minn); 2015 Apr; 21(2 Neuro-oncology):345-54. PubMed ID: 25837900
[TBL] [Abstract][Full Text] [Related]
20. Preclinical therapeutic targets in diffuse midline glioma.
Meel MH; Kaspers GJL; Hulleman E
Drug Resist Updat; 2019 May; 44():15-25. PubMed ID: 31202081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
